ProPharma Group, a portfolio company of Odyssey Investment Partners, has acquired iSafety Systems.
iSafety Systems is headquartered in India’s biotech hub, Hyderabad, and provides end-to-end pharmacovigilance and safety solutions and services to pharmaceutical, biotechnology, and medical device companies globally.
“We welcome the iSafety team into the ProPharma Group family. This acquisition continues to strengthen ProPharma Group’s position as the leading global provider of regulatory and compliance consulting, clinical research services, pharmacovigilance, and medical information.
With our shared higher purpose of improving patient health and safety, the combined company provides more operational flexibility and additional PV service capacity for supporting the evolving needs of our growing and high-volume clients,” said Dawn Sherman, ProPharma Group’s CEO.
With a multilingual cross-functional team of pharmacovigilance experts and SME’s, iSafety’s team bolsters and extends ProPharma Group’s global reach and capabilities in over 130 countries throughout the USA, Europe, Latin America and Asia-Pacific, the company said.
“Joining ProPharma Group offers a great synergistic value to clients as their requirements evolve and grow globally. We look forward to working together to ensure product quality and safety for patients around the world,” said Dr. Chander Bhave, CEO, iSafety Systems.
ProPharma Group continues to expand its global presence with more than 1,900 employees worldwide.
